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Abstract: 
New therapies for leukaemia are urgently needed. Carrots have been suggested as a potential treatment for 
leukaemia in traditional medicine and have previously been studied in other contexts as potential sources of 
anticancer agents. Indicating that carrots may contain bioactive compounds, which may show potential in 
leukaemia therapies. This study investigated the effects of five fractions from carrot juice extract (CJE) on 
human lymphoid leukaemia cell lines, together with five purified bioactive compounds found in Daucus carota 
L, including: three polyacetylenes (falcarinol, falcarindiol and falcarindiol-3-acetate) and two carotenoids (beta-
carotene and lutein). Their effects on induction of apoptosis using Annexin V/PI and Caspase 3 activity assays 
analysed via flow cytometry and inhibition of cellular proliferation using Cell Titer Glo assay and cell cycle 
analysis were investigated. Treatment of all three lymphoid leukaemia cell lines with the fraction from carrot 
extracts which contained polyacetylenes and carotenoids was significantly more cytotoxic than the 4 other 
fractions. Treatments with purified polyacetylenes also induced apoptosis in a dose and time responsive manner. 
Moreover, falcarinol and falcarindiol-3-acetate isolated from Daucus carota L were more cytotoxic than 
falcarindiol. In contrast, the carotenoids showed no significant effect on either apoptosis or cell proliferation in 
any of the cells investigated. This suggests that polyacetylenes rather than beta-carotene or lutein are the 
bioactive components found in Daucus carota L and could be useful in the development of new leukemic 
therapies. Here, for the first time, the cytotoxic effects of polyacetylenes have been shown to be exerted via 
induction of apoptosis and arrest of cell cycle.  
 
 
Keywords: Leukaemia / Polyacetylenes/ Carotenoids / Daucus carota L /Apoptosis/ Cell proliferation. 
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1. Introduction: 
Leukaemia is a major source of morbidity and mortality worldwide and is the most common childhood cancer 
[1], however the causes of childhood leukaemia remain mostly unclear [2]. According to the Leukaemia & 
Lymphoma Society about 28,500 patients are diagnosed annually in the UK with a blood cancer [3]. 
Approximately 40% of patients diagnosed with leukaemia survive for at least five years after diagnosis [4]. The 
main treatments for leukaemia are chemotherapy, radiotherapy, growth factors, and bone marrow or stem cell 
transplants. Treatment for leukaemia varies depending on age, level of fitness and type of leukaemia [5]. The 
current therapies however, show a wide range of side effects: e.g. drop in blood cell count, complete hair loss, 
diarrhoea, tiredness, nausea and reduced fertility [6]. Thus, new treatments with potentially different 
mechanisms than those presently used as chemotherapy agents could support existing treatments of leukaemia, 
if their use could reduce side effects without compromising efficacy. Promising sources of such new agents 
could be found in common foods, which contain bioactive compounds with potential anti-cancer properties. 
Experimental and epidemiological evidence suggests that high intake of phytochemicals derived from fruits, 
vegetables and whole grains such as polyphenols and carotenoids are associated with low incidence of cancers 
such as lung and prostate cancer [7]. In traditional medicine, wild carrots (known as ‘Queen Anne’s Lace’) have 
been used as treatments for leukaemia and other cancers throughout history [8-10]. In 2002, a study 
demonstrated that individuals who have a high level of serum carotene or who eat more fruits and vegetables 
high in carotenoids, showed a lower risk of developing cancers, particularly lung cancer [11]. In addition, 
epidemiological studies have shown that dietary intake of α-carotene (which is almost exclusively derived from 
carrots) is significantly associated with reduced risk of cancer than intake of other similar phytochemicals [12]. 
We have previously demonstrated that carrot (Daucus carota L) juice extract contains bioactive agents which 
prevent leukaemia cell proliferation and induce cell death in human leukaemia cell lines preferentially to non-
tumour control cells [13]. Carrot juice extract (CJE) treatment of four human myeloid and four human lymphoid 
leukaemia cell lines showed an inhibition in progression of cell cycle and induction of programmed cell death 
(apoptosis) [13]. In addition, lymphoid leukaemia cell lines were more sensitive to CJE treatment than myeloid 
cell lines [13].  
 
Daucus carota L is a rich source of a number of compounds thought to have bioactive properties, including 
polyacetylenes and carotenoids. Polyacetylenes found within Daucus carota L include falcarinol (FaOH), 
falcarindiol (FaDOH) and falcarindiol-3-acetate (FaDOAc) and have demonstrated bioactive actions in a 
number of cell lines [14-16]. Falcarinol from Apiaceae vegetables including carrots has been shown to be 
cytotoxic against an acute lymphoblastic leukaemia cell line (CEM-C7H2), with an IC50 of 3.5 µM [17].  
Moreover, Purup and colleagues (2009), investigated the inhibitory effect of polyacetylenes from carrots 
(falcarinol and falcarindiol) and American ginseng (falcarinol and panaxydol) demonstrating that falcarinol was 
a potent inhibitor of cell proliferation of CaCo-2 cells (human epithelial colorectal carcinoma cells) [15]. Young 
et al (2007) demonstrated in vitro that falcarinol (from carrots) at concentrations above 10 µM decreased cell 
proliferation of CaCo-2 cells after 48 and 72 h [18]. Another study, tested the effect of falcarinol on the 
development of azoxymethane (AOM) induced colon preneoplastic lesions in male rats and found that feeding 
rats with freeze-dried carrots containing 35 µg falcarinol per gram, or rat feed supplemented with the same dose 
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of falcarinol delayed the development of tumours and aberrant crypt foci (ACF) following 18 weeks [19]. 
Furthermore, several in vitro and in vivo studies investigating falcarinol and falcarindiol treatments, showed 
cytotoxic effects on a range of cell types over a range of concentrations between 3.5 - 100 µM [15,17-19]  
(Table 1).   
 
In addition to polyacetylenes, β-carotene is thought to be a bioactive agent within carrots and has been shown to 
induce apoptosis in tumor cells [20]. Treatment of U937 and HL-60 leukaemia cell lines showed a significant 
decrease in the number of viable cells following treatment with 20 µM commercial β -carotene [20]. Induction 
of apoptosis was also seen and indicated by arrest at G1 phase of cell cycle [20]. In contrast, others have 
demonstrated that high intake of β -carotene has no effects in the treatment or prevention of cancer. Hansen and 
colleagues (2003), compared the cytotoxicity of falcarinol ((9Z)-heptadeca-1,9-dien- 4,6-diyn-3-ol), obtained 
from carrots, with β-carotene and the results showed that falcarinol had inhibitory effects between 4.09 and 40.9 
µM , while β-carotene showed no effect in the concentration range 0.001 – 186 nM [21]. Studies of smokers 
(aged 50–69 years) who smoked five or more cigarettes a day showed that consumption of 20 mg β-carotene 
supplements daily resulted in a higher risk of lung cancer compared to smokers without β-carotene 
supplementation, despite this the same study also confirmed a significant protective effect of baseline dietary β-
carotene intake (most of which would be from carrots) [22,23]. One possible explanation for this contradictory 
observation could be that other compounds in fruits or vegetables which are high in β-carotene are responsible 
for the protective effects seen [24,25]. 
 
Lutein is another potential bioactive carotenoid, found within carrots, which has demonstrated anti-tumor 
activity towards lung cancer of ddY mice when given orally with a mixture of olive oil three times a week [26]. 
Furthermore, this carotenoid showed selective cytotoxicity and induced apoptosis in transformed mammary 
epithelial cells but not normal human mammary epithelial cells [27]. Semi purified lutein has also been shown 
to inhibit mammary cancer growth in mice, by the down regulation of Bcl-2 gene (anti-apoptotic) and up 
regulation of Tp53 and Bax (pro-apoptotic) mRNA [28]. They also found that mice fed a lutein-supplemented 
diet displayed tumours that were 30 to 40% smaller compared to mice on un-supplemented diets 50 days post-
feeding [28]. 
 
Here, we aimed to identify the bioactive compounds within Daucus carota L responsible for the induction of 
apoptosis and inhibition of cellular proliferation in leukemic cell lines. We separated five fractions from carrot 
juice extracts (CJE) using solid phase extraction to isolate different groups of compounds, and investigated their 
effects on induction of apoptosis. Moreover we used pure bioactive chemicals from Daucus carota L (including: 
three polyacetylenes: falcarinol, falcarindiol and falcarindiol-3-acetate, and two carotenoids: β-carotene and 
lutein) to investigate their individual effects on induction of apoptosis and inhibition of cellular proliferation. 
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2.  Materials and Methods: 
2.1 Cell lines and culture 
Three lymphoid leukaemia cell lines, which we previously have shown respond to whole carrot juice extracts 
[13], were used within this study, these were: CCRF-CEM (acute lymphoblastic leukaemia) (ATCC: CCL-119, 
Middlesex, UK); Jurkat (peripheral blood T cell leukaemia) (ATCC: TIB-152, Middlesex, UK); and MOLT-3 
(acute lymphoblastic leukaemia patient released following chemotherapy) (ATCC: CRL-1552, Middlesex, UK). 
Two million cells per 75 cm² flask (Invitrogen, Paisley, UK) in RPMI 1640 medium (Invitrogen, Paisley, UK) 
supplemented with 10% (v/v) fetal bovine serum, 1.5 mM L-Glutamine and 100 µg/mL penicillin/streptomycin 
(complete RPMI) were incubated at 37 ºC with 5% CO2. Following incubation cells from T75 cm² flasks were 
transferred to centrifuge tubes and centrifuged for 10 minutes at 400 g at room temperature, supernatant 
removed and cells re-suspended in 20 mL of complete RPMI media. The number of cells was assessed using a 
haemocytometer and 12 well plates (Fisher Scientific, Leicestershire, UK) seeded with 0.5 x 10
6 
cells per well. 
2.2 Fraction separation from carrot juice extracts (CJE) 
Solid Phase Extraction (SPE) using Strata C18E GIGA tubes (Phenomenex, Hartsfield, UK) were used to 
separate fractions from the carrot juice extracts used previously [13]. Firstly, tubes were pre-equilibrated by 
washing with 50 mL of acetonitrile then 50 mL of 0.1 % formic acid / ultra pure water (v/v) (Sigma, Poole, UK). 
Carrot juice extract (prepared as previously [13]) was sterile filtered through 0.22 µm syringe filters (Invitrogen, 
Paisley, UK) and diluted 1:1 with sterile distilled water prior to addition of 50 mL diluted juice to the C18E 
column, after which the unbound fraction which passed directly through the column was collected (fraction A). 
Then, 50 mL each of ultra pure water, acetonitrile, acetone and ethyl acetate were added to the tube to collect 
water (fraction B), acetonitrile (fraction C), acetone (fraction D) and ethyl acetate (fraction E), fractions 
respectively. Each fraction was dried using freeze drying (MODULYOD-230 freeze dryer, Thermo, UK) at -30 
to -80 °C for fractions A and B or dried under a nitrogen stream at room temperature for fractions C, D and E. 
According to the required dilution: water, unbound and acetonitrile fractions were dissolved in distilled water; 
acetone fraction in methanol, and ethyl acetate fraction in DMSO (Sigma, Poole, UK). 
2.3 Treatment Regimes 
2.3.1 Treatment with fractions: 
The total weight of 10 mL dried whole juice was calculated together with individual weight/volume of each 
fraction. The weight of dried fractions equivalent to 62.5 µL whole juice was calculated to match concentrations 
of compounds within 6.25% CJE treatments used previously [13]. The weight equivalent to 6.25% treatment 
was resuspended in 1 µL appropriate solvent. Cells (0.5 x 10
6
) were then treated with 1, 2 or 4 µL of fraction 
solution (equivalent to compound concentration within 6.25, 12.5 or 25% whole CJE as studied previously) for 
48 h.  Cells were also treated with acetone fraction for additional time points: 24 and 72 h and an additional 
concentration equivalent to 50% whole CJE. 
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2.3.1.1 HPLC Analysis of carrot juice extraction and five fractions: 
Dried whole juice and dried fractions (A, B, C, D and E) each corresponding to thirty milliliter juice were 
dissolved by adding 1 mL each of water, acetonitrile and ethyl acetate to generate polar and non-polar layers on 
the bottom and top of the sample respectively. The top non-polar layer contained the polyacetylenes and 
carotenoids from the whole juice whereas the bottom polar layer contained phenolic acids. High performance 
liquid chromatography (HPLC) was used to detect polyacetylenes, carotenoids and phenolic acids using 
previously described methods [29].  
2.3.1.2 MS/MS Analysis of acetone fraction: 
Tandem mass spectrometry/mass spectrometry (MS/MS) was performed on 30 mL dried acetone fraction, 
isolated from CJE to confirm the presence of polyacetylenes and caroteniods within this fraction. Acetone 
fraction was dissolved in 200 µL each of ultra pure water, ethyl acetate and acetonitrile to generate polar and 
non-polar layers as described for HPLC analysis. The top non-polar acetone layer, which was yellow in color, 
was injected manually and analysed on negative ionisation mode on a Finnigan LCQ mass spectrometer 
(Thermo Electron Corporation, Basingstoke, UK). MS/MS was performed to investigate the peaks 
corresponding to the MW of the three polyacetylenes (falcarinol MS/MS 243, falcarindiol MS/MS 259 and 
falcarindiol-3-acetate MS/MS 301) and β-carotene and lutein (beta-carotene MS/MS 535.8 and lutein MS/MS 
567.87). The collision energy used ranged between 30  and 40 for all compounds. Data was acquired at m/z 
ranging from 65-400 and 140-600 for detecting polyacetylenes and caratenoids respectively.  
2.3.2 Treatment with polyacetylenes: 
All Polyacetlyenes were purified from carrots as described previously and were obtained from Newcastle 
University [29] (Newcastle University, Human Nutrition Research Centre, Newcastle, UK). Polyacetylenes were 
dissolved in methanol (Sigma, Poole, UK) to give stock concentrations falcarinol (6.8 mM / mL), falcarindiol 
(1.5 mM / mL) and falcarindiol-3-acetate (5 mM/ mL) and diluted in serum free media to treat half a million
 
cells with 0, 0.5, 5, 25, 50 and 100 µM and incubated for 24 h. Methanol was added to the control cells at 
equivalent concentration for vehicle controls. 
 
2.3.3 Treatment with β-carotene: 
Beta-carotene (Sigma, Poole, UK) was dissolved in DMSO (Sigma, Poole, UK) to stock concentration (10 g/ 
mL) and diluted in serum free media to treat half a million
 
cells with 0, 0.5, 5, 25, 50 and 100 µM and incubated 
for 24 h. DMSO was added to the control cells at equivalent concentrations for vehicle controls. 
 
2.3.4 Treatment with lutein: 
Lutein  (Extrasynthese, Genay, France) was dissolved in methanol (Sigma, Poole, UK) containing 1% v/v 
dichloromethane to stock concentration (5 mg) and diluted in serum free media to treat half a million cells with 
0, 0.5, 5, 25, 50 and 100 µM. Methanol containing 1% v/v dichloromethane was added to the control cells at 
equivalent concentrations for vehicle controls. 
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2.4 Investigating the apoptotic cell death following the treatment with five fractions of carrot juice extract, 
polyacetylenes, beta-carotene and lutein: 
Induction of apoptosis was assessed using Annexin V (BD, Oxford, UK) and propidium iodide (PI) staining  
(Sigma, Poole, UK) and examined using  flow cytometry. Caspase 3 activity assay (Cambridge Bioscience, 
Cambridge, UK) was also used to investigate apoptosis and examined using flow cytometry. 
 
2.4.1 Flow cytometric analysis using Annexin V/PI stain: 
Following treatments cellular content from each well were transferred to Eppendorf tubes and centrifuged for 5 
minutes at 400 g, 4 ºC. Supernatant was removed and cells resuspended in 100 µl Dulbecco's Phosphate-
Buffered Saline (DPBS) (Invitrogen, Paisley, UK). Cells were washed twice in 100 µl binding buffer (10 mM 
HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) (BD, Oxford, UK). Cells were resuspended in 50 µl 
binding buffer and 5 µl of Annexin V and incubated at 4 ºC for 20 minutes in the dark. Finally, 300 µl of PI (50 
µg / mL) was added and samples directly analyzed on the flow cytometer using a BD FACS Calibur instrument 
and data analyzed using FlowJo software (Tree Star, Treestar, Ashland, OR, USA). Live cells with undamaged 
membranes exclude PI, while the membranes of damaged and dead cells are permeable to PI. Thus live cells 
were PI and Annexin V negative, cells undergoing apoptosis were Annexin V positive and PI negative and cells 
that were in late apoptosis or already dead via apoptosis or necrosis were positive for both Annexin V and PI. 
 
2.4.2 Flow cytometric analysis using Caspase 3 stain:  
Following treatments 200 µl of cell suspensions from each well were transferred to flow cytometry tubes and 5 
µl of caspase 3 stain (0.2 mM) (Promega, Southampton, UK) added to each sample and incubated in the dark for 
10 minutes. Samples were analyzed on the flow cytometer using a BD FACS Calibur instrument (BD, Oxford, 
UK) and data analyzed using Flow Jo software (Tree Star, Treestar, Ashland, OR, USA). 
 
2.5 Investigating the cell proliferation inhibition following the treatment with five fractions of carrot juice 
extract, polyacetylenes, beta-carotene and lutein: 
 
2.5.1 Investigating the ATP level:  
Twenty five thousand cells per well were treated in white 96-wells plates (Fisher Scientific, Loughborough, UK) 
with acetone fraction, three polyacetylenes and two commercial carotenoids (β-carotene and lutein) at 
concentration's ranging from 0 to 100 µM, and after 24 h, 25 µl of cell titer-glo reagent from Cell Titer Glo 
Luminescent Cell Viability Assay kit (Promega, Southampton, UK) were added to each well, and incubated for 
10 min at room temperature. The luminescence was measured using Wallac Victor 2 1420 luminescence 
detector. The ATP level, which is an indicator of metabolically active cells, was quantified to determine the 
number of live cells following treatment.   
 
2.6 Investigating the cell cycle inhibition following the treatment with polyacetylenes: 
 
2.6.1 Cell cycle analysis:  
Half a million cells per well were treated with falcarinol, falcarindiol or falcarindiol-3-acetate and after 24 h 
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cells were transferred to Eppendorf tubes and centrifuged for 5 minutes at 400 g at 4 ºC. The supernatant was 
removed, and cells washed twice in 100 µl cold DPBS. Cells were fixed by adding 100 µl of 80 % ethanol and 
stored overnight at -20 C. Then, cells were washed twice with cold DPBS prior to addition of 300 µl of PI 
(Sigma, Poole UK) (50 µg/ mL) and 50 µl of RNase (0.1 unit/ mL) (Sigma, Poole UK). Samples were stained 
overnight at 4 ºC and analyzed on the flow cytometer with BD FACS Calibur instrument and data analysed with 
FlowJo software using Waston (pragmatic) equation (Tree Star, Treestar, Ashland, OR, USA). 
 
Statistical analysis 
Average and Standard error of the mean (SEM) was calculated and Stats Direct was used to test whether data 
followed a normal distribution using a Shapiro Wilke test. Data did not follow a normal distribution, thus data 
was transformed using the 'logit' transformation and data statistically analyzed using one way ANOVA and 
Tukey post hoc tests to investigate significant differences. Results were considered statistically significant when 
P ≤ 0.05. 
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3. Results 
3.1 Effect on Apoptosis 
3.1.1. Effect of five fractions from carrot juice extracts (CJE) on apoptosis: 
Treatment of three human lymphoid leukaemia cell lines (CCRF-CEM, Jurkat and MOLT-3) with unbound, 
water, acetonitrile and ethyl acetate fractions showed no effect on induction of apoptosis following 48 h at 
equivalent concentrations to those seen in 6.25, 12.5 and 25% whole CJE (Fig 1). Conversely, the acetone 
fraction (fraction D) showed a significant decrease in the number of live cells and significant increase in both 
apoptotic and dead cells in dose dependent manner within all three leukemic cell lines following 24 h of 
treatment (control v/s acetone fraction equivalent to concentration in 25% whole CJE P  0.05) (Fig 2). In 
addition, treatment of CCRF-CEM and Jurkat but not MOLT-3 cells with the acetone fraction from CJE showed 
increased response following 48 h, however no further increase in response was seen following 72 h (Fig 2). 
3.1.2 HPLC and MS/MS analysis of fractions from carrot juice extracts:  
The analysis of the fractions prepared from CJE using HPLC and UV detection showed that both polyacetylenes 
and carotenoids were present in the acetone fraction but not in the other fractions and phenolic acids were 
concentrated in the acetonitrile fraction (data not shown). Moreover, MS/MS negative electrospray ionisation 
mode the measured masses of falcarinol, falcarindiol, falcarindiol-3-acetate, β-carotene  and lutein were detected 
at molecular weight -1 due to loss one molecule of Hydrogen [30]. The cleavage on these compounds at 
different positions generated multiple smaller compounds which could be identified as fragments of the 
compound in question (Fig 3). In addition, mass spectrometry demonstrated the relative concentrations of these 
compounds where lutein was the most abundant out of the five compounds investigated within the acetone 
fraction. Falcarindiol-3-acetate and falcarinol were observed at similar levels and were the second and third most 
abundant compounds with β-carotene and falcarindiol at the lowest levels out of the five investigated.  
 
3.1.3 Effect of polyacetylenes (falcarinol, falcarindiol and falcarindiol-3-acetate) from carrots on apoptosis: 
Falcarinol and falcarindiol-3-acetate significantly decreased the percent of live cells and induced apoptosis in 
CCRF-CEM, Jurkat and MOLT-3 lymphoid leukemic cells after treatment with 25, 50 and 100 µM following 24 
h stimulation to a greater extent than falcarindiol. In contrast, lower concentrations of falcarinol induced a small 
increase in viability within Jurkat cells, although this did not reach significance (Fig. 4). Moreover, these cell 
lines displayed differing sensitivity levels when treated with falcarinol: CCRF-CEM (acute lymphoblastic 
leukaemia) was the most sensitive cell line, with 45% of cells live following 24 h  treatment and 0 % alive 
following 48 h treatment with 25 µM (Fig 4 and Table 2). Similarly, after 24 h treatment with 100 µM 
falcarindiol-3-acetate CCRF-CEM cell line was the most affected with 0% alive. While Jurkat cell line 
(peripheral blood T cell leukaemia) and MOLT-3 cell line (acute lymphoblastic leukaemia patient released 
following chemotherapy) showed 20% and 45% cells remaining viable respectively (Fig 4). The inhibitory 
potency effect of different polyacetylenes from Daucus carota L was falcarindiol-3-acetate > falcarinol > 
falcarindiol (Fig 4 and Table 2). 
 
3.1.3. Effect of Carotenoids (beta-carotene and lutein) on apoptosis: 
Treatment with β-carotene on CCRF-CEM cells at concentrations of 25 µM, 50 µM and 100 µM showed a small 
but significant decrease in the number of live cells, whereas Jurkat and MOLT 3 cells were only affected by the 
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highest concentration of β-carotene (100 µM) (Fig 4). Beta-carotene treatments failed to reach AP50 even 
following 100 µM treatments. Lutein treatments failed to induce apoptosis in any cell line at any concentration 
(Fig 4 and Table 2).  
 
3.2 Effect on cell proliferation 
3.2.1. Effect of acetone fraction from carrot juice extracts (CJE) on cell proliferation: 
The effect of the acetone fraction on cell proliferation following treatment with concentrations equivalent to  
concentrations of compounds found within 12.5%, 25% and 50% of whole CJE after 24, 48 and 72 h showed a 
significant decrease in the ATP level within cultures of CCRF-CEM, Jurkat and MOLT-3 leukaemia cell lines 
indicating decreased cell number (P ≤ 0.05). CCRF-CEM and MOLT-3 cells showed no significant difference in 
ATP levels within treatments between time points, whereas Jurkat cells showed increased response following 72 
h compared to 24 and 48 h treatments (Fig 5). 
 
3.2.2. Effect of polyacetylenes (falcarinol, falcarindiol and falcarindiol-3-acetate) from Daucus carota L on 
cell proliferation: 
Leukaemia cell lines showed differential response when treated with 0.5 µM, 5 µM, 25 µM, 50 µM and 100 µM 
polyacetylenes at 24 h. All three cell lines showed greatest sensitivity to falcarinol, with significant inhibition in 
ATP levels at concentrations  5 µM in CCRF CEM cells,  25 µM in Jurkat cells and  5 µM in MOLT 3 cells. 
CCRF-CEM and Jurkat cells showed greater sensitivity to falcarindiol while the MOLT-3 cell line was more 
affected after treatment with 100 µM falcarindiol-3-acetate than falcarindiol (Fig 6 and Table 3).  
 
3.2.3. Effect of beta-carotene and lutein on cell proliferation: 
All leukaemia cell lines showed a small decrease in the ATP level when assessed at 24 h after the 100 µM 
treatments with β-carotene although this only reached significance in Jurkat cells (P ≤ 0.05) (Fig 6). Conversely 
an increase in ATP levels was observed within Jurkat cells treated with doses of 50 M β-carotene or less 
although this did not reach significance (P > 0.05). Treatment of all three cell lines with any concentration of 
lutein did not induce any effect on ATP levels (Fig 6 and Table 3). 
 
3.2.4. Effect of polyacetylenes (falcarinol, falcarindiol and falcarindiol-3-acetate) from Daucus carota L on 
cell cycle: 
Lymphoblastic leukaemia cell lines showed differential response to different polyacetylene types following 24 h. 
However, all three cell lines showed a significant decrease in G0/G1 and a significant increase in S phase of the 
cell cycle when treated with 25 µM of falcarinol (Data shown for CCRF-CEM only Fig 7A). Moreover, the 
CCRF-CEM cell line showed an increase in sub-G0 population, which is an indicator for apoptotic cells, with 25 
µM falcarinol (Fig 7 B). In contrast, falcarindiol and falcarindiol-3-acetate showed no effect on CCRF-CEM 
when treated with 5 and 25 µM and assessed at 24 h (Fig 7A).  
 
The results of this study demonstrated that falcarinol and falcarindiol-3-acetate are the most active type of 
polyacetylenes in carrots that induce apoptosis to a greater extent than falcarindiol (Fig 4). In addition, falcarinol 
inhibited cell proliferation of CCRF-CEM with an IC50 of 12 µM, Jurkat with an IC50 of 28 µM and MOLT-3 
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with an IC50 of 46 µM. However, both carotenoids β-carotene and lutein showed only small effects on cell 
proliferation and apoptosis in all examined lymphoid leukaemia cell lines even after treatment with high 
concentrations.  
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4. Discussion: 
The present study isolated different compounds by solid phase extraction (SPE) from CJE and identified a 
number of bioactive chemicals within Daucus carota L. Crude extracts from Daucus carota L have previously 
been shown to be cytotoxic to leukaemia cells, inhibiting proliferation and inducing apoptosis in leukaemia cell 
lines preferentially to non-tumour control cells [13]. Here, we investigated which bioactive compounds found 
within Daucus carota L are responsible for this potential anticancer activity. 
Solid Phase extraction enabled separation of potential agents into different fractions, separating the polar non-
retained compounds including sugars, acids, and proteins into the unbound and water fractions, polyphenolic 
agents in the acetonitrile fraction and polyacetylenes and carotenes in the acetone fraction. Interestingly the only 
fraction which demonstrated any significant biological activity was the acetone fraction which was shown to 
contain both polyacetylenes and carotenes. These compounds were then investigated individually to identify 
which of these induced apoptosis and inhibited proliferation in lymphoid leukaemia cell lines. The acetonitrile 
fraction which contained phenolic acids failed to induce significant apoptosis within any of the three cell types 
investigated, treatments were at the concentrations equivalent to those present in the whole juice extracts 
investigated previously and thus was not investigated further. The negative results found on phenolic fractions 
(Acetonitrile fraction) could be due to low levels of phenolic acids within this cultivar of  Daucus carota L, 
indeed orange carrots contain lower levels of phenolic acids than other coloured varieties such as purple carrots 
[31], thus it is possible that phenolic fractions from these richer sources of phenolic acid cultivars may show 
biological activity.  
The current study demonstrated that pure commercial β -carotene showed minimal effects on induction of 
apoptosis or inhibition of cell growth following 24 h. Similarly Hansen et al., (2003) showed no inhibitory 
effect for β -carotene between 0.001 - 100 µg mL-1, where as falcarinol showed a very potent inhibitory effect in 
the concentrations 1 and 10 µg mL
-1
 on mammary epithelial cells [21]. However, Upadhyaya et al., (2007) 
demonstrated a significant toxic effect of β -carotene at a dose of 20-100 µM towards U937 (histiocytic 
lymphoma) and HL-60 (Human promyelocytic leukaemia cells) when assessed after 12 h [20]. They also 
reported a number of morphological abnormalities with inclusion of apoptotic bodies and DNA fragmentation in 
both cell lines [20]. The reasons for these conflicting results are unclear, whether the source of β -carotene used 
in these previous studies was not pure, and thus may have contained additional agents such as polyacetylenes, or 
it is possible that the differing effects are due to variation in sensitivity of different cell types.  
In addition to β -carotene, lutein is another type of carotenoid, which was expressed at high concentrations in the 
acetone fraction from CJE. However within the three human lymphoid leukaemia cell lines investigated here no 
effect was seen on apoptosis or cell proliferation in concentrations from 0.5 µM to100 µM following 24 and 48 
h. On the other hand, an in vivo study on mouse mammary cancer has demonstrated that dietary lutein (semi 
purified) inhibits cancer growth by decreasing the expression of anti-apoptotic gene Bcl-2 and up regulating pro-
apoptotic genes: Tp53 and Bax [28]. These mice fed with lutein also showed 35% smaller tumor size on day 50 
compared with mice fed with an un-supplemented diet [28]. Lutein (semi-purified) treatment has also been 
shown to induce apoptosis selectively in transformed human mammary cells but not within normal mammary 
cells after 4 days [27]. The difference in observations between our results and the results from these studies 
13 
 
could indicate a difference in sensitivity between mammary cancers and leukaemia. Alternatively as the lutein 
treatment within the studies on mammary cancers was not pure, it is possible these extracts were contaminated 
with other bioactive agents such as polyacetylenes which could have provided the effects that were attributed to 
lutein.  
In this study, we demonstrated that falcarinol, and falcarindiol-3-acetate isolated from Daucus carota L 
significantly decreased the percentage of live cells and increased the number of both apoptotic and dead cells 
within three human lymphoid leukaemia cell lines (CCRF-CEM, Jurkat and MOLT-3) at concentrations 25-100 
µM to a greater extent than falcarindiol, which agrees with previous studies on alternative cell types (Table 1) 
[15,17-19]. However, total cell number significantly increased following treatment with low concentrations of 
falcarindiol-3-acetate within Jurkat and MOLT 3 cells, although this did not reach significance. Similarly, 
treatment with falcarinol (0.5 and 1 µM) showed an increase in cell number of CaCo-2 after 72 h [18]. The 
increase in cell proliferation at low concentrations, known as hormesis, is a characteristic feature of bioactive 
compounds [32,33], and has been observed in all studies on other cell types where appropriate ranges have been 
studied [15, 18, 21, 25, 34]. Interestingly within the cell types studied here we only demonstrated a hormesis 
effect for falcarindiol-3-acetate. Purup et al (2009) showed that falcarinol, isolated from carrots, showed a more 
potent effect on inhibition of cell proliferation in a human cancer intestinal cell line (CaCo-2) than falcarindiol-
type polyacetylene [15]. Another study by Young and colleagues (2007), showed that the polyacetylene 
falcarinol, extracted from carrots, could cause a decrease in cell proliferation and increase apoptosis in CaCo-2 
(human colon carcinoma) cells at high concentrations (≥20 µM) after 72 h [18].  Here we showed an IC50 of 
falcarinol of 12, 15 and 35 µM within CCRF-CEM, Jurkat and MOLT-3 leukaemia cell lines respectively, this 
concentration range collaborates the dose responses of falcarinol in a number of previous studies (Table 1) 
[15,17-19] . 
Few studies to date have investigated the effects of polyacetylenes on cell proliferation. Previous work on carrot 
extracts containing 2.5 µg/mL of falcarinol and 10 µg/mL of falcarindiol on both a normal human epithelial cell 
line (FHs 74 Int.) and a human colon cancer cell line (CaCo-2) showed significant inhibition of cell proliferation 
under basal growth conditions [15]. Here, we found that all three types of polyacetylenes showed an inhibition 
on cell proliferation, indicated by reduced ATP level, when assessed at 24 h. However, the cell lines showed 
various levels of sensitivity to different polyacetylenes: CCRF-CEM and Jurkat were affected following 
treatment with falcarinol and falcarindiol; whereas: MOLT-3 cells were more affected after treatment with 
falcarinol: falcarindiol-3-acetate and falcarindiol respectively.  
Here, we investigated, for the first time, the potential of polyacetylenes to arrest cells at stages of cell cycle. The 
treatment of three lymphoid leukaemia cell lines (CCRF-CEM, Jurkat and MOLT-3) with 25 µM falcarinol 
showed a significant cell accumulation at S phase of the cell cycle when assessed at 24 hours, whereas the other 
polyacetylenes failed to show responses on cell cycle. Similarly, an in vitro study showed S phase arrest on 
CCRF-CEM, Jurkat and MOLT-3 cell lines when treated with (25%) whole carrot juice extraction for 24 h [13]. 
Arrest of cells within S phase can indicate disruption of DNA repair mechanisms and prevention of cellular 
proliferation which could pose an additional therapeutic approach to reducing tumour cell burden together 
within induction of cell death. 
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However the hormesis effects seen following treatment with falcarindiol-3-acetate could indicate that the 
concentrations attained via consumption may not be sufficient to generate the anti-cancer actions and could 
potentially be detrimental to cancer prevention. Identification of the concentrations attained via consumption 
and circulation via the blood and targeting to the bone marrow will be essential to determine if the 
concentrations of the agents required to induce the anti-cancer effect could be attained via consumption. 
Previous studies, have indicated that plasma concentration of polyacetylenes only reach 0.01 µM suggesting that 
normal consumption can not lead to the doses required to generate cytotoxic properties [25]. Feeding studies of 
falcarinol in a rat colon cancer model, demonstrated biological effects with a dose of 35 μg falcarinol per gram 
feed were equal to the effects of entire carrots at the same dose [19]. Corroborating our study which suggests 
falcarinol is the major bioactive species within carrots, and suggests bioactive levels of falcarinol can feasibly be 
attained via consumption [19]. Alternatively these agents could be extracted and delivered pharmaceutically. 
The acute LD50 of falcarinol within mice after injection has been shown to be around 400 µM [35], thus the 
AP50 of falcarinol of 18-68 μM is promising for targeted toxicity to cancerous cells in particular if they act 
synergistically with other drugs allowing each drug to be used at a lower dose causing fewer side effects than 
when used on its own, such as that suggested for sulphoraphane [36,37,38]. Future studies will focus on the 
elucidation of the mechanisms of action of these polyacetylenes particularly in relation to induction of apoptosis 
and cell cycle arrest. Together with investigation into whether they can work synergistically with current 
chemotherapeutic agents will aid our understanding of the usefulness of these agents in leukaemia therapies.  
The significance of the our study lies in the observation that the polyacetylenes falcarinol and falcarindiol-3-
acetate types of polyacetylenes isolated from Daucus carota L induced apoptosis and inhibited cell cycle in 
human lymphoid leukaemia cells, and falcarindiol induced apoptosis in CCRF–CEM cells only whereas, the two 
types of carotenoids; β-carotene and lutein showed little effect on any of the three examined cell lines. 
Suggesting that the polyacetylenes rather than carotenoids demonstrate effects on apoptosis and proliferation on 
cancer cells, this would resolve the paradox where increased carrot consumption is associated with reduced 
cancer incidence despite the failed associations with beta-carotene. The combined effect of polyacetylenes on 
induction of apoptosis and inhibition of cell cycle indicates that these agents could be beneficial in the treatment 
of leukaemia.  
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concentration; HPLC; High-performance liquid chromatography; SPE, solid phase extraction;  PI, propidium 
iodide; UV, ultraviolet. 
 
Acknowledgements  
The authors wish to thank Dr. Gordon McDougall (Plant Products and Food Quality, The James Hutton Institute, 
Invergowrie, Dundee DD2 5DA, Scotland) for advice on Solid Phase Extraction and Dr. Sarah Haywood-Small 
for help on Flow Cytometry.  The study was funded by The Saudi Arabian Ministry of Health. 
 
  
16 
 
Figure Legends: 
 
Figure 1: Apoptotic induction by CJE fractions generated by Solid phase extraction within three leukaemia cell 
lines (CCRF-CEM, Jurkat and MOLT-3). Cells treated for 48 h with unbound, water, acetonitrile, acetone and 
ethyl acetate fractions at concentrations equivalent to compound concentrations found in 6.25,12.5 and 25% 
whole CJE, Apoptosis investigated using Annexin V/PI staining. Data are presented as means ± standard error. * 
= P ≤ 0.05 
 
Figure 2: Induction of apoptosis by acetone fraction generated by SPE of carrot juice extracts within three 
leukaemia cell lines (CCRF-CEM , Jurkat and MOLT-3). Cells treated for 24, 48, 72 h with acetone fractions at 
concentrations equivalent to compound concentrations found in 12.5, 25, and 50% whole CJE, Apoptosis 
investigated using caspase 3 activity assay and analysed by flow cytometry. Live cells normalized to vehicle 
controls and presented as means ± standard error. * = P ≤ 0.05. 
 
Figure 3: Negative ionization mode MS/MS on acetone fraction isolated from CJE. MS/MS performed for 
falcarinol (M - H)
 _ 
ion
 
at 243 (A), falcarindiol at 259 (B), falcarindiol-3 acetate at 301 (C), beta-carotene at 535 
(D) and lutein at 567 (E). 
 
Figure 4: Apoptotic induction within three leukaemia cell lines (CCRF-CEM , Jurkat and MOLT-3). Cells 
treated for 24 h with falcarinol, falcarindiol, falcarindiol-3-acetate, β-carotene or lutein. Apoptosis investigated 
using caspase 3 activity assay and analysed by flow cytometry. Live cells normalized to vehicle controls and 
presented as means ± standard error. * = P ≤ 0.05. 
 
Figure 5: Cellular proliferation investigated by measuring ATP levels within three leukaemia cell lines (CCRF-
CEM , Jurkat and MOLT-3). Following treatment for 24, 48 and 72 h with acetone fractions at concentrations 
equivalent to compound concentrations found in 12.5, 25, and 50% whole CJE. ATP levels determined using 
Cell Titer Glo assay. ATP levels normalized to vehicle controls and presented as means ± standard error. * = P 
≤ 0.05. 
 
Figure 6: Cellular proliferation investigated by measuring ATP levels within three leukaemia cell lines (CCRF-
CEM , Jurkat and MOLT-3). Following treatment for 24 h with falcarinol, falcarindiol, falcarindiol-3-acetate, β-
carotene or lutein. ATP levels determined using Cell Titer Glo assay. ATP levels normalized to vehicle controls 
and presented as means ± standard error. * = P ≤ 0.05. 
 
Figure 7: Accumulation of CCRF-CEM cells in S Phase following 24 h treatment with falcarinol. No effect was 
observed with the other polyacetylenes. Proportion of cells within each stage of cell cycle analysed within 
CCRF-CEM following 24 h of treatment with three polyacetylenes types (falcarinol, falcarindiol and 
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falcarinidiol-3acetate (A). Cell cycle histograms displayed for CCRF-CEM treated with 0, 0,5 and 25 µM 
falcarinol analysed with FlowJo software using Waston pragmatic model (B) 
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Treatment Cells IC50 concentraction References 
Falcarinol CEM-C7H2 3.5 µM  Zidorn et al, 2005 
Falcarinol CaCo-2 10.2 µM Purup et al, 2009 
Falcarinol RPMI 27.4 µM Zidorn et al, 2005 
Falcarinol U937 30.1 µM Zidorn et al, 2005 
Falcarinol HRT-18 42.3 µM Zidorn et al, 2005 
Falcarinol CaCo-2 50- 100 µM Young et al, 2007 
Falcarinol HT2919 60 µM Zidorn et al, 2005 
Falcarindiol RPMI 29.6 µM Zidorn et al, 2005 
Falcarindiol CEM-C7H2 29.8 µM Zidorn et al, 2005 
Falcarindiol U937 31.8 µM Zidorn et al, 2005 
Falcarindiol CaCo-2 38 µM Purup et al, 2009 
Falcarindiol HRT-18 > 100 µM Zidorn et al, 2005 
Falcarindiol HT2919 > 100 µM Zidorn et al, 2005 
 
Table1: Falcarinol and falcarindiol effects on cell lines and animal models from published literature [15
,
17
-
19] 
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 FAL FAOH F3A Beta-carotene Lutein 
CCRF-CEM 26µM 45 µM 23 µM Not reached 50% Not reached 50% 
Jurkat 18 µM No reached 50% 30 µM Not reached 50% Not reached 50% 
MOLT-3 68 µM No reached 50% 38 µM Not reached 50% Not reached 50% 
 
Table2: This table summarises the AP50 inhibition effect (causing apoptosis of 50% of the cells) for falcarinol, 
falcarindiol, falcarindiol-3-acetate, β-carotene and lutein treatment when assessed at 24 hours. 
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 FAL FAOH F3A Beta-carotene Lutein 
 
CCRF-CEM 
 
12 µM 29 µM 45 µM Not reached 50% Not reached 50% 
Jurkat 
 
15 µM 45 µM 77 µM Not reached 50% Not reached 50% 
MOLT-3 35 µM No effect 71 µM Not reached 50% Not reached 50% 
 
Table 3: This table summarises the IC50 inhibition effect for falcarinol, falcarindiol, falcarindiol-3-acetate, β-
carotene and lutein treatment when assessed at 24 hours. 
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